WaveMan
WaveMan · SEC 13F
Blue Owl Capital Holdings LP 13F holdings
> Search tickers & screens ⌘K
LIVE

Blue Owl Capital Holdings LP 13F holdings

Blue Owl Capital Holdings LP reported 70 positions with a total reported value of $658.0M as of 2026-06-30, in its 13F for Q2 2026, filed 2026-08-11. Top holdings by reported value: SPCX SPACE EXPLORATION TECHN CORP (36.3%), AKTS AKTIS ONCOLOGY INC (15.0%), CGEM CULLINAN THERAPEUTICS INC (4.3%), LRMR LARIMAR THERAPEUTICS INC (4.2%), NCDL NUVEEN CHURCHILL DIRECT LEND (4.0%). Against 2026-03-31 it opened 14 new positions and exited 13. Next 13F due by 2026-11-14, the legal deadline 45 days after the quarter ending 2026-09-30.

Email me when Blue Owl Capital Holdings LP files its 13F

A free account follows up to 10 funds. New 13F filings arrive in your daily or weekly digest. No password and no card.

Top holdings

25 largest of 70 positions · reported value as of 2026-06-30
HoldingSharesReported value% of portfolio
SPCX SPACE EXPLORATION TECHN CORP1,398,815$239.0M36.3%
AKTS AKTIS ONCOLOGY INC3,070,219$99.0M15.0%
CGEM CULLINAN THERAPEUTICS INC1,539,764$28.0M4.3%
LRMR LARIMAR THERAPEUTICS INC9,163,157$27.9M4.2%
NCDL NUVEEN CHURCHILL DIRECT LEND2,143,626$26.6M4.0%
MPLT MAPLIGHT THERAPEUTICS INC729,929$26.2M4.0%
COF CAPITAL ONE FINL CORP119,757$24.0M3.7%
OBDC BLUE OWL CAPITAL CORPORATION2,045,070$22.2M3.4%
FISN DEEP FISSION INC1,333,333$14.7M2.2%
DELL DELL TECHNOLOGIES INC32,961$14.2M2.2%
HLLY HOLLEY INC4,376,888$11.2M1.7%
EYPT EYEPOINT INC762,594$10.9M1.7%
SGMT SAGIMET BIOSCIENCES INC1,260,544$9.7M1.5%
CRVS CORVUS PHARMACEUTICALS INC608,600$9.1M1.4%
ARTV ARTIVA BIOTHERAPEUTICS INC874,542$8.5M1.3%
CMPX COMPASS THERAPEUTICS INC3,624,076$7.9M1.2%
CNDT CONDUENT INC5,036,595$7.4M1.1%
RYTM RHYTHM PHARMACEUTICALS INC61,455$6.8M1.0%
CMPS COMPASS PATHWAYS PLC450,000$6.4M1.0%
RARE ULTRAGENYX PHARMACEUTICAL IN182,638$6.1M0.9%
PVLA PALVELLA THERAPEUTICS INC NE36,259$5.5M0.8%
IMA IMAGENEBIO INC917,692$5.4M0.8%
VIRIDIAN THERAPEUTICS INC260,000$4.8M0.7%
IMMX IMMIX BIOPHARMA INC437,552$4.5M0.7%
ORIC ORIC PHARMACEUTICALS INC400,000$4.3M0.7%
SEC FORM 13F · Q2 2026 · VALUES AS REPORTED, NOT PRICES

New positions this quarter

Held at 2026-06-30, not at 2026-03-31 · 14 in all · reported value as of 2026-06-30
HoldingSharesReported value% of portfolio
SPCX SPACE EXPLORATION TECHN CORP1,398,815$239.0M36.3%
COF CAPITAL ONE FINL CORP119,757$24.0M3.7%
FISN DEEP FISSION INC1,333,333$14.7M2.2%
ARTV ARTIVA BIOTHERAPEUTICS INC874,542$8.5M1.3%
VIRIDIAN THERAPEUTICS INC260,000$4.8M0.7%
CABA CABALETTA BIO INC714,710$2.2M0.3%
CHIME FINL INC89,878$1.8M0.3%
CYBIN INC59,911$396.0K<0.1%
CELC CELCUITY INC1,249$130.7K<0.1%
USDE STABLECOINX INC250,000$102.5K<0.1%
MURANO GLOBAL INVT PLC261,875$62.9K<0.1%
ZEO ZEO ENERGY CORP250,000$10.0K<0.1%
LVWR LIVEWIRE GROUP INC400,000$8.0K<0.1%
NVNIF NVNI GROUP LIMITED200,000$6.0K<0.1%

Sold out

Held at 2026-03-31, gone by 2026-06-30 · 13 in all · reported value as of 2026-03-31
HoldingShares 2026-03-31Reported value% of portfolio then
CVEO CIVEO CORP CDA180,475$4.8M1.3%
KALVISTA PHARMACEUTICALS INC215,000$4.3M1.2%
OVID OVID THERAPEUTICS INC1,904,666$4.2M1.1%
PLRX PLIANT THERAPEUTICS INC2,969,199$3.7M1.0%
EPD ENTERPRISE PRODS PARTNERS L31,290$1.2M0.3%
OPTX SYNTEC OPTICS HLDGS INC803,132$867.4K0.2%
MLYS MINERALYS THERAPEUTICS INC200,000$590.0K0.2%
CAH CARDINAL HEALTH INC1,718$363.0K<0.1%
VKTX VIKING THERAPEUTICS INC50,000$68.0K<0.1%
GOCOQ GOHEALTH INC40,770$61.6K<0.1%
GPCR STRUCTURE THERAPEUTICS INC100,000$25.0K<0.1%
OLMA OLEMA PHARMACEUTICALS INC200,000$10.0K<0.1%
BTMCQ BITCOIN DEPOT INC50,000$1.0K<0.1%

Biggest increases and decreases

Positions held at both quarter ends, by change in shares · reported value as of 2026-06-30

Increases

HoldingShares 2026-03-31Shares 2026-06-30ChangeReported value
DELL DELL TECHNOLOGIES INC13,89932,961+137.1%$14.2M
SGMT SAGIMET BIOSCIENCES INC333,8771,260,544+277.5%$9.7M
LRMR LARIMAR THERAPEUTICS INC8,095,7079,163,157+13.2%$27.9M
ORIC ORIC PHARMACEUTICALS INC150,000400,000+166.7%$4.3M
LENZ LENZ THERAPEUTICS INC506,722756,722+49.3%$4.3M
EVMN EVOMMUNE INC100,000180,000+80.0%$2.4M
CRVS CORVUS PHARMACEUTICALS INC545,000608,600+11.7%$9.1M
PVLA PALVELLA THERAPEUTICS INC NE31,25936,259+16.0%$5.5M
STARWOOD PPTY TR INC158,545196,355+23.8%$3.2M
CMPX COMPASS THERAPEUTICS INC3,341,5253,624,076+8.5%$7.9M
HLLY HOLLEY INC4,236,8884,376,888+3.3%$11.2M

Decreases

HoldingShares 2026-03-31Shares 2026-06-30ChangeReported value
CMPS COMPASS PATHWAYS PLC1,804,504450,000-75.1%$6.4M
MPLT MAPLIGHT THERAPEUTICS INC1,005,929729,929-27.4%$26.2M
CGEM CULLINAN THERAPEUTICS INC1,909,7641,539,764-19.4%$28.0M
RARE ULTRAGENYX PHARMACEUTICAL IN302,638182,638-39.7%$6.1M
ELDN ELEDON PHARMACEUTICALS INC1,419,912566,509-60.1%$2.2M
AKTS AKTIS ONCOLOGY INC3,161,3483,070,219-2.9%$99.0M
EYPT EYEPOINT INC912,594762,594-16.4%$10.9M
AQST AQUESTIVE THERAPEUTICS INC1,347,932942,932-30.0%$3.9M
ENGN ENGENE THERAPEUTICS INC4,927,530511,177-89.6%$148.2K
CNTX CONTEXT THERAPEUTICS INC5,089,0152,934,015-42.3%$1.6M
IMMX IMMIX BIOPHARMA INC547,552437,552-20.1%$4.5M
KPLT KATAPULT HOLDINGS INC405,4215,421-98.7%$5.4K
CIK 1858703 · 13F FILINGS ON EDGAR · INFORMATIONAL ONLY

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-28 · For informational purposes only, not investment advice.
Privacy · Terms